BROOKFIELD CORP (BN)

CA11271J1075 - Common Stock

57.86  +0.37 (+0.64%)

After market: 57.012 -0.85 (-1.47%)

Fundamental Rating

3

Overall BN gets a fundamental rating of 3 out of 10. We evaluated BN against 220 industry peers in the Capital Markets industry. BN has a medium profitability rating, but doesn't score so well on its financial health evaluation. BN has a decent growth rate and is not valued too expensively.



4

1. Profitability

1.1 Basic Checks

BN had positive earnings in the past year.
BN had a positive operating cash flow in the past year.
Of the past 5 years BN 4 years were profitable.
In the past 5 years BN always reported a positive cash flow from operatings.

1.2 Ratios

With a Return On Assets value of 0.15%, BN is not doing good in the industry: 77.42% of the companies in the same industry are doing better.
BN's Return On Equity of 1.59% is on the low side compared to the rest of the industry. BN is outperformed by 75.58% of its industry peers.
Looking at the Return On Invested Capital, with a value of 4.03%, BN is in line with its industry, outperforming 50.69% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for BN is below the industry average of 6.99%.
The last Return On Invested Capital (4.03%) for BN is above the 3 year average (3.94%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 0.15%
ROE 1.59%
ROIC 4.03%
ROA(3y)0.54%
ROA(5y)0.47%
ROE(3y)4.9%
ROE(5y)4.3%
ROIC(3y)3.94%
ROIC(5y)3.62%

1.3 Margins

BN's Profit Margin of 0.81% is on the low side compared to the rest of the industry. BN is outperformed by 75.58% of its industry peers.
BN's Profit Margin has declined in the last couple of years.
BN's Operating Margin of 24.52% is in line compared to the rest of the industry. BN outperforms 45.16% of its industry peers.
BN's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 18.62%, BN is doing worse than 72.81% of the companies in the same industry.
BN's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 24.52%
PM (TTM) 0.81%
GM 18.62%
OM growth 3Y10.13%
OM growth 5Y6.12%
PM growth 3YN/A
PM growth 5Y-30.16%
GM growth 3Y1.18%
GM growth 5Y6.07%

1

2. Health

2.1 Basic Checks

BN has less shares outstanding than it did 1 year ago.
The number of shares outstanding for BN has been increased compared to 5 years ago.
The debt/assets ratio for BN has been reduced compared to a year ago.

2.2 Solvency

BN has an Altman-Z score of 0.48. This is a bad value and indicates that BN is not financially healthy and even has some risk of bankruptcy.
BN has a worse Altman-Z score (0.48) than 67.74% of its industry peers.
BN has a Debt/Equity ratio of 5.26. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of BN (5.26) is worse than 85.71% of its industry peers.
Industry RankSector Rank
Debt/Equity 5.26
Debt/FCF N/A
Altman-Z 0.48
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

BN has a Current Ratio of 0.84. This is a bad value and indicates that BN is not financially healthy enough and could expect problems in meeting its short term obligations.
BN's Current ratio of 0.84 is on the low side compared to the rest of the industry. BN is outperformed by 61.29% of its industry peers.
A Quick Ratio of 0.66 indicates that BN may have some problems paying its short term obligations.
BN has a Quick ratio of 0.66. This is in the lower half of the industry: BN underperforms 67.74% of its industry peers.
Industry RankSector Rank
Current Ratio 0.84
Quick Ratio 0.66

4

3. Growth

3.1 Past

BN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 92.39%, which is quite impressive.
BN shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 5.73% yearly.
Looking at the last year, BN shows a decrease in Revenue. The Revenue has decreased by -4.73% in the last year.
Measured over the past years, BN shows a quite strong growth in Revenue. The Revenue has been growing by 11.06% on average per year.
EPS 1Y (TTM)92.39%
EPS 3YN/A
EPS 5Y5.73%
EPS Q2Q%15.07%
Revenue 1Y (TTM)-4.73%
Revenue growth 3Y15.19%
Revenue growth 5Y11.06%
Sales Q2Q%-15.62%

3.2 Future

BN is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 17.71% yearly.
The Revenue is expected to decrease by -38.48% on average over the next years. This is quite bad
EPS Next Y30.79%
EPS Next 2Y15.95%
EPS Next 3Y17.71%
EPS Next 5YN/A
Revenue Next Year-83.18%
Revenue Next 2Y-55.75%
Revenue Next 3Y-38.48%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 15.27, BN is valued correctly.
Compared to the rest of the industry, the Price/Earnings ratio of BN is on the same level as its industry peers.
Compared to an average S&P500 Price/Earnings ratio of 27.55, BN is valued a bit cheaper.
BN is valuated correctly with a Price/Forward Earnings ratio of 14.20.
Compared to the rest of the industry, the Price/Forward Earnings ratio of BN is on the same level as its industry peers.
When comparing the Price/Forward Earnings ratio of BN to the average of the S&P500 Index (24.00), we can say BN is valued slightly cheaper.
Industry RankSector Rank
PE 15.27
Fwd PE 14.2

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, BN is valued cheaper than 86.18% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 10.3

4.3 Compensation for Growth

BN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as BN's earnings are expected to grow with 17.71% in the coming years.
PEG (NY)0.5
PEG (5Y)2.66
EPS Next 2Y15.95%
EPS Next 3Y17.71%

1

5. Dividend

5.1 Amount

BN has a yearly dividend return of 0.54%, which is pretty low.
BN's Dividend Yield is slightly below the industry average, which is at 9.57.
With a Dividend Yield of 0.54, BN pays less dividend than the S&P500 average, which is at 2.36.
Industry RankSector Rank
Dividend Yield 0.54%

5.2 History

The dividend of BN decreases each year by -5.12%.
BN has paid a dividend for at least 10 years, which is a reliable track record.
The dividend of BN decreased recently.
Dividend Growth(5Y)-5.12%
Div Incr Years1
Div Non Decr Years1

5.3 Sustainability

87.94% of the earnings are spent on dividend by BN. This is not a sustainable payout ratio.
DP87.94%
EPS Next 2Y15.95%
EPS Next 3Y17.71%

BROOKFIELD CORP

NYSE:BN (12/26/2024, 8:04:01 PM)

After market: 57.012 -0.85 (-1.47%)

57.86

+0.37 (+0.64%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)11-14 2024-11-14/bmo
Earnings (Next)02-06 2025-02-06/amc
Inst Owners64.33%
Inst Owner Change2.71%
Ins Owners10.96%
Ins Owner ChangeN/A
Market Cap95.30B
Analysts76.84
Price Target64.51 (11.49%)
Short Float %0.86%
Short Ratio6.61
Dividend
Industry RankSector Rank
Dividend Yield 0.54%
Dividend Growth(5Y)-5.12%
DP87.94%
Div Incr Years1
Div Non Decr Years1
Ex-Date12-16 2024-12-16 (0.08)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)34.18%
Min EPS beat(2)-0.3%
Max EPS beat(2)68.65%
EPS beat(4)3
Avg EPS beat(4)20.85%
Min EPS beat(4)-0.3%
Max EPS beat(4)68.65%
EPS beat(8)6
Avg EPS beat(8)-3.67%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)1592.59%
Min Revenue beat(2)1473.07%
Max Revenue beat(2)1712.11%
Revenue beat(4)4
Avg Revenue beat(4)798.76%
Min Revenue beat(4)0.84%
Max Revenue beat(4)1712.11%
Revenue beat(8)8
Avg Revenue beat(8)413.33%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)17.54%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-2.89%
EPS NY rev (1m)5.51%
EPS NY rev (3m)5.56%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.87%
Revenue NY rev (1m)-1.19%
Revenue NY rev (3m)-0.68%
Valuation
Industry RankSector Rank
PE 15.27
Fwd PE 14.2
P/S 1.05
P/FCF N/A
P/OCF 16.45
P/B 2.05
P/tB N/A
EV/EBITDA 10.3
EPS(TTM)3.79
EY6.55%
EPS(NY)4.07
Fwd EY7.04%
FCF(TTM)-8.5
FCFYN/A
OCF(TTM)3.52
OCFY6.08%
SpS55.31
BVpS28.21
TBVpS-15.64
PEG (NY)0.5
PEG (5Y)2.66
Profitability
Industry RankSector Rank
ROA 0.15%
ROE 1.59%
ROCE 5%
ROIC 4.03%
ROICexc 4.14%
ROICexgc 4.97%
OM 24.52%
PM (TTM) 0.81%
GM 18.62%
FCFM N/A
ROA(3y)0.54%
ROA(5y)0.47%
ROE(3y)4.9%
ROE(5y)4.3%
ROIC(3y)3.94%
ROIC(5y)3.62%
ROICexc(3y)4.09%
ROICexc(5y)3.75%
ROICexgc(3y)5.05%
ROICexgc(5y)4.55%
ROCE(3y)4.88%
ROCE(5y)4.48%
ROICexcg growth 3Y16.62%
ROICexcg growth 5Y7.18%
ROICexc growth 3Y14.15%
ROICexc growth 5Y5.45%
OM growth 3Y10.13%
OM growth 5Y6.12%
PM growth 3YN/A
PM growth 5Y-30.16%
GM growth 3Y1.18%
GM growth 5Y6.07%
F-Score6
Asset Turnover0.18
Health
Industry RankSector Rank
Debt/Equity 5.26
Debt/FCF N/A
Debt/EBITDA 7.62
Cap/Depr 203.03%
Cap/Sales 21.72%
Interest Coverage 250
Cash Conversion 18.06%
Profit Quality N/A
Current Ratio 0.84
Quick Ratio 0.66
Altman-Z 0.48
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)227.2%
Cap/Depr(5y)208.74%
Cap/Sales(3y)19.73%
Cap/Sales(5y)17.68%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)92.39%
EPS 3YN/A
EPS 5Y5.73%
EPS Q2Q%15.07%
EPS Next Y30.79%
EPS Next 2Y15.95%
EPS Next 3Y17.71%
EPS Next 5YN/A
Revenue 1Y (TTM)-4.73%
Revenue growth 3Y15.19%
Revenue growth 5Y11.06%
Sales Q2Q%-15.62%
Revenue Next Year-83.18%
Revenue Next 2Y-55.75%
Revenue Next 3Y-38.48%
Revenue Next 5YN/A
EBIT growth 1Y25.89%
EBIT growth 3Y26.86%
EBIT growth 5Y17.86%
EBIT Next Year754.34%
EBIT Next 3Y61.94%
EBIT Next 5YN/A
FCF growth 1Y-32.69%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-28.11%
OCF growth 3Y-8.27%
OCF growth 5Y4.59%